Mark Enyedy, a former executive vice president at Shire Plc , will take over ImmunoGen Inc. as the company’s next president and chief executive officer.

Spurred by an infusion of $170 million, three clinical trials and a deep pipeline of cancer therapies, Blueprint Medicines has quadrupled its employee base.

April 25, 2016 By Alex Keown, BioSpace.com Breaking News Staff     DUBLIN — John T. Hendrickson has been tapped as the new chief executive officer of Perrigo Company PLC (PRGO), after former CEO Joseph Papa left the company to helm rival Valeant Pharmaceuticals (VRX). Last week BioSpace (DHX) reported Papa was the favorite to […]

October 19, 2015 (Parsippany, NJ): Guidemark Health furthers its commitment to its strategy and branding efforts by naming Martin Mannion as Chief Strategy Officer. With 25 years spent in marketing and advertising agencies, Mannion brings substantial healthcare strategy knowledge as well as diverse disease category experience to the Guidemark Health family. Previously he was Chief […]

Boston-based Third Rock Ventures announced today it had raised $52 million to launch a company called Decibel Therapeutics to work on hearing loss.   Decibel Therapeutics will be headquartered at 215 First Street in Cambridge, Mass. near Kendall Square. The company has already started to hire, planning on having 50 to 60 scientists working by […]

MD Anderson Cancer Center, located in Houston, Texas, announced yesterday that together with Seattle-based Theraclone Sciences, Inc., it was launching an immuno-oncology antibody discovery company, OncoResponse. In addition, OncoResponse closed a Series A financing round worth $9.5 million, co-led by ARCH Venture Partners, Canaan Partners and MD Anderson. Also participating were William Marsh Rice University […]

ATLANTA – Alcon (ACL), a division of Novartis (NVS), is investing $250 million into an expansion of its Atlanta-area facility that will add more than 300 jobs, the Atlanta Business Chronicle reported this morning. The expansion will allow Alcon to focus on the manufacturing and development of contact lenses, including Dailies, AquaComfort Plus, Dailies Total1 […]

Copenhagen, Denmark-based Novo Nordisk (NVO) and the governor of North Carolina, Pat McCrory, announced today that the company will spend between $1.2 and $1.7 billion to build a new manufacturing facility in Johnston County, N.C.   The new manufacturing plant is expected to create approximately 700 jobs over the next five years. It will manufacture […]